References
- Stavinoha W. B., Emerson G. A., Larsen V. “The effect of some sulfur compounds on thallotoxicosis in mice,”. Toxicol. Appl. Pharmacol. 1959; 1: 638–646
- Siegenthaler P. “Der antitoxische Effect verschiedener Substanzen bei der experimentellen Thalliumvergiftung,”. Praxis 1960; 26: 633–635
- Bass M. J. Am. Osteopath. Assoc. 1963; 63: 229, Op. cit. [5]
- Rieders F., Cordova V. F. “Effect of sodium diethyldithiocarbamate (NaDEDTC) on urinary thallium excretion in man,”. Pharmacologist 1965; 7: 162
- Sunderman F. W., Jr. “Diethyldithiocarbamate therapy of thallotoxicosis,”. Am. J. med. Sci. 1967; 25: 209–220
- Schwetz B. A., O'Neil P. V., Voelker F. A., Jakobs D. W. “Effects of diphenylthiocarbazone and diethyldithiocarbamate on the excretion of thallium by rats,”. Toxicol. Appl. Pharmacol. 1967; 10: 79
- Moeschlin S. Exogene und endogene (Hyperparathyreoidism:us, Wegenersche Granulomatose) Vergiftungen. Helv. Med. Acta 1967, Suppl. 47: 75–100
- Lund A. “The effect of various substances on the excretion and the toxicity of thallium in the rat,”. Acta Pharmacol. Toxicol. 1956; 12: 260–268
- Chamberlain Ph. H., Stavinoha W. B., Davis H., Kniker W. T., Panos T. C. “Thallium poisoning,”. Pediatrics 1958; 22: 1170–1182
- Smith D. H., Doherty R. A. “Thallitoxicosis: Report of three cases in Massachusetts.”. Pediatrics 1964; 34: 480–490
- Gehring P. J., Hammond P. B. “The interrelationship between thallium and potassium in animals.”. Pharmacol. Exp. Therap. 1967; 255: 187–201
- Moeschlin S. Klinik und Therapie der Vergiftungen4th ed. Georg Thieme Verlag, Stuttgart 1965, Eng. ed.:, Poisoning Diagnosis and Treatment, Grune and Stratton, New York, 1964
- , Personal communication from the Merck Laboratories
- Kamerbeek H. H., Rauws A. G., ten Ham M., van Heijst A. N. P. “Dangerous redistribution of thallium by treatment with sodium diethyldithiocarbamate,”. Acta Med. Scand. 1971; 189: 149–154